Treg Cell Therapy in Autoimmunity: Perspective on Target Patient Populations & Clinical Strategy

Time: 1:30 pm
day: Conference Day Two

Details:

  • Developing "armed" Tregs as a promising therapeutic option to induce immune tolerance
  • Understanding considerations for diseases and target patient populations
  • Giving an overview of the clinical development strategy 

Speakers: